AR and prostate carcinoma: These findings, coupled with previous xenograph data implicating a potential role of ERBB2 in the promotion of prostate cancer invasiveness or metastasis, strongly suggest a potential crosstalk between the ERBB2 signaling pathway and the androgen/androgen receptor signaling pathway in promoting prostate cancer metastasis.